[{"ID":"6768_15-2021_NCT01911351","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of coronary artery disease?\n\n#2: Does the patient have a history of anxiety?\n\n#3: Is the patient's current anxiety score less than 10?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question.\n\nOnce you have answered all questions, I will provide the final eligibility determination based on the clinical trial's inclusion and exclusion criteria.","PROBA":0.9706727645},{"ID":"30737_65-2021_NCT02287506","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, confirmed with molecular analysis 7 years ago.\n\n#2: Is the patient between 18 and 50 years old?\n\nYes, the patient is 25 years old, which is within the age range of 18 to 50 years.\n\n#3: Was the patient diagnosed with diabetes within the last year?\n\nNo, the patient was diagnosed with diabetes 7 years ago, which is outside the time frame of within the last year.\n\n#4: Is the patient unwilling or unable to provide informed consent?\n\nNo, the patient is willing and able to provide informed consent.\n\nBased on the criteria, the patient is not eligible for the clinical trial because they do not meet the inclusion criterion of being diagnosed with diabetes within the last year.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9979215042},{"ID":"5479_12-2021_NCT03686527","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair or replacement surgery?\n\nYes, the patient is planned for mitral valve repair or replacement surgery.\n\n#4: Does the patient have a history of gestational diabetes mellitus?\n\nNo, the patient does not have a history of gestational diabetes mellitus.\n\n#5: Does the patient have hypertension with pregnancy?\n\nNo, the patient does not have hypertension with pregnancy.\n\n#6: Does the patient have obesity?\n\nNo, the patient does not have obesity.\n\n#7: Has the patient undergone laser eye surgery?\n\nNo, the patient has not undergone laser eye surgery.\n\n#8: Has the patient undergone cataract surgery?\n\nNo, the patient has not undergone cataract surgery.\n\n#9: Has the patient undergone foot surgery (shorten bone length)?\n\nYes, the patient has undergone foot surgery (shorten bone length).\n\n#10: Does the patient have a history of allergies?\n\nNo, the patient does not have a history of allergies.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.9950386899},{"ID":"7035_15-2021_NCT04254692","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of coronary artery disease?\n\nYes, the patient has a history of coronary artery disease.\n\n#2: Does the patient have a history of bleeding disorders?\n\nNo, the patient does not have a history of bleeding disorders.\n\n#3: Is the patient on anticoagulation therapy?\n\nNo, the patient is not on anticoagulation therapy.\n\n#4: Is the patient medically cleared for surgery?\n\nYes, the patient is medically cleared for surgery.\n\n#5: Is the patient taking opioid pain medications on a regular basis prior to surgery?\n\nNo, the patient is not taking opioid pain medications on a regular basis prior to surgery.\n\n#6: Does the patient have a history of opioid abuse and\/or dependence?\n\nNo, the patient does not have a history of opioid abuse and\/or dependence.\n\nBased on the criteria above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9949352444},{"ID":"35329_75-2021_NCT00307450","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\n\nYes, the patient's disease is ranked as mild (Hoehn-Yahr Stage I).\n\n#3: Does the patient have levodopa-induced dyskinesias?\n\nThe patient is complaining of shaking and slow movement, which could be indicative of levodopa-induced dyskinesias.\n\n#4: Is the patient taking Levodopa and Trihexyphenidyl?\n\nYes, the patient is being offered Levodopa and Trihexyphenidyl.\n\n#5: Does the patient have any exclusion criteria?\n\nBased on the information provided, the patient does not have any exclusion criteria (atypical parkinsonian syndromes, treatment with antipsychotics, epilepsy or seizure history, deep brain stimulation other than DBS in STN, pregnant or lactating women, severe dementia).\n\nTherefore, based on the information provided, the patient would likely be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9920018484},{"ID":"5288_12-2021_NCT01242397","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair or replacement surgery within the next 6 months?\n\nNo, the patient is not planned for mitral valve repair or replacement surgery within the next 6 months.\n\n#4: Is the patient currently indicated for CRT?\n\nNo, the patient is not currently indicated for CRT.\n\n#5: Does the patient have life expectancy <6 months?\n\nNo, the patient does not have life expectancy <6 months.\n\n#6: Is the patient pregnant?\n\nNo, the patient is not pregnant.\n\n#7: Does the patient have significant aortic stenosis?\n\nNo, the patient does not have significant aortic stenosis.\n\n#8: Does the patient have uncontrolled hypertension?\n\nNo, the patient does not have uncontrolled hypertension.\n\n#9: Does the patient have mitral valve stenosis?\n\nNo, the patient does not have mitral valve stenosis.\n\n#10: Does the patient have severe mitral valve calcification?\n\nNo, the patient does not have severe mitral valve calcification.\n\n#11: Does the patient have ruptured chordae tendinea or papillary muscle?\n\nNo, the patient does not have ruptured chordae tendinea or papillary muscle.\n\n#12: Does the patient have mitral valve leaflet disorders (ie. endocarditis, lupus, tumors, rheumatic heart disease)?\n\nNo, the patient does not have mitral valve leaflet disorders (ie. endocarditis, lupus, tumors, rheumatic heart disease).\n\n#13: Does the patient have chronic mitral leaflet degeneration (ie. Marfans)?\n\nYes, the patient has chronic mitral leaflet degeneration (ie. Marfans).\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9986501347},{"ID":"30804_65-2021_NCT02816099","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, which is an inclusion criterion for the clinical trial.\n\n#2: Is the patient's glycaemic balance uncontrolled?\n\nYes, the patient has uncontrolled diabetes, which is an inclusion criterion for the clinical trial.\n\n#3: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9968900567},{"ID":"35706_75-2021_NCT03876327","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Does the patient complain of constipation?\n\nYes, the patient complains of slowness of movement and tremors, which could be related to constipation.\n\n#3: Is the patient clinically stable and properly treated pharmacologically?\n\nNo, the patient is not clinically stable and is not properly treated pharmacologically, as they are experiencing symptoms and have not undergone a screening colonoscopy for colon cancer.\n\n#4: Is the patient willing and able to undergo a colonoscopy?\n\nYes, the patient is willing and able to undergo a colonoscopy.\n\n#5: Does the patient have any exclusion criteria?\n\nYes, the patient has hypertension and hypercholesterolemia, but these conditions are not exclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9921581207},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a history of severe hypertension?\n\nNo, the patient does not have a history of severe hypertension, so this exclusion criterion is not met.\n\n#2: Is the patient non-smoker?\n\nYes, the patient is a non-smoker, so this exclusion criterion is met.\n\n#3: Is the patient non-morbidly obese?\n\nNo, the patient is not morbidly obese, so this exclusion criterion is not met.\n\n#4: Does the patient have a history of falls?\n\nNo, the patient does not have a history of falls, so this exclusion criterion is not met.\n\n#5: Does the patient have any orthopaedic, neurological, pulmonary, or cardiac problems?\n\nNo, the patient does not have any of these conditions, so this exclusion criterion is not met.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9906038181},{"ID":"17169_36-2021_NCT02610660","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have pulmonary hypertension?\n\nNo, the patient does not have pulmonary hypertension.\n\n#2: Is the patient a child or adolescent?\n\nYes, the patient is a child or adolescent.\n\n#3: Does the patient have a follow-up period of 3 years?\n\nNo, the patient does not have a follow-up period of 3 years.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not have pulmonary hypertension and do not meet the inclusion criteria of the trial. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9989915737},{"ID":"6703_15-2021_NCT01360918","TOPIC_YEAR":2021,"RESPONSE":"#1: Age\nThe patient is 70 years old, which is above the upper age limit of 70 years specified in the exclusion criteria. Therefore, the patient is excluded based on age.\n\n#2: Pregnancy\nThe patient is not pregnant, so this criterion does not apply.\n\n#3: Contraindications for oral anticoagulant agents\nThere is no information in the patient note about contraindications for oral anticoagulant agents, so this criterion does not apply.\n\n#4: Emergency operation\nThe patient was admitted with fevers, rigors, and bandemia, which suggests that the operation was not an emergency. Therefore, this criterion does not apply.\n\n#5: Concomitant valve replacement\nThe patient note does not mention anything about valve replacement, so this criterion does not apply.\n\n#6: Severely enlarged LA (>50 mm) on echocardiography\nThe patient note does not mention anything about echocardiography, so this criterion does not apply.\n\nBased on the above, the patient is excluded from the clinical trial due to age.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9882431773},{"ID":"30417_65-2021_NCT00211510","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, confirmed with molecular analysis 7 years ago.\n\n#2: Is the patient at least 18 years old?\n\nYes, the patient is 25 years old, which is above the age of 18.\n\n#3: Is the patient willing and able to use the Paradigm 722 System?\n\nNo, the patient is not willing and able to use the Paradigm 722 System because the patient is already using the Paradigm 715 insulin pump only.\n\n#4: Does the patient have any exclusion criteria?\n\nYes, the patient has a history of unresolved tape allergy or skin conditions, which is an exclusion criterion for the clinical trial.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not meet the inclusion criteria (willing and able to use the Paradigm 722 System) and they have an exclusion criterion (history of unresolved tape allergy or skin conditions).\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9967855219},{"ID":"5466_12-2021_NCT03549052","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair\/replacement surgery?\n\nYes, the patient is planned for mitral valve repair\/replacement surgery.\n\n#4: Does the patient have pulmonary hypertension?\n\nYes, the patient has pulmonary hypertension.\n\n#5: Is the patient's left ventricular ejection fraction (LVEF) less than 45%?\n\nNo, the patient's LVEF is 65%.\n\n#6: Does the patient have any other causes of pulmonary hypertension?\n\nNo, the patient does not have any other causes of pulmonary hypertension.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9968286012},{"ID":"30870_65-2021_NCT03605979","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 1 diabetes?\n\nYes, the patient has type 1 diabetes, confirmed with molecular analysis 7 years ago.\n\n#2: Is the patient > 18 years old?\n\nYes, the patient is 25 years old, which is above the age of 18.\n\n#3: Does the patient have any serious diseases that could interfere with the study?\n\nNo, the patient's past medical history is not significant for any other medical issues.\n\n#4: Is the patient pregnant?\n\nNo, the patient is not pregnant.\n\n#5: Does the patient have hearing loss or low vision?\n\nNo, the patient does not have hearing loss or low vision.\n\n#6: Is the patient able to use the devices required for the study?\n\nYes, the patient is able to use the devices required for the study.\n\nTherefore, based on the criteria for the clinical trial, the patient is eligible to participate.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9936441534},{"ID":"7000_15-2021_NCT03955081","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient does not meet the inclusion criteria because the study is only recruiting patients aged 18 years and older. The patient is 70 years old, which is outside the age range for the study.\n\n#2: Does the patient meet any of the exclusion criteria?\n\nThe patient does not meet any of the exclusion criteria listed.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the answer is [B] Excluded.","PROBA":0.9827405191},{"ID":"6882_15-2021_NCT02882503","TOPIC_YEAR":2021,"RESPONSE":"# Step 1: Check the inclusion criteria\n\nThe patient is a 70-year-old woman with a history of CAD and recent abdominal mass, fevers, and bandemia. She meets the inclusion criteria of having a pancreatic tumor, as the biopsy results showed pancreatic adenocarcinoma at the head of the pancreas.\n\n# Step 2: Check the exclusion criteria\n\nThe patient does not meet the exclusion criteria of being pregnant or having other malignancies within the past five years. She also does not have any active metal implanted devices, such as a pacemaker. However, she does have a history of coronary artery disease, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, and hypothyroidism, which are all listed as exclusion criteria.\n\n# Step 3: Check for any other factors that may disqualify the patient\n\nThe patient has a history of diverticulitis, which may be a factor in her current presentation. However, it is not explicitly listed as an exclusion criterion. Additionally, the patient is taking antibiotics for her infection, which may be a factor in her eligibility.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9868705225},{"ID":"6848_15-2021_NCT02580422","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have pancreatic cancer?\n\nNo, the patient does not have pancreatic cancer. The patient has a history of CAD and abdominal mass, but the biopsy results showed pancreatic adenocarcinoma.\n\n#2. Does the patient have a history of congestive heart failure (NYHA class III or IV)?\n\nNo, the patient does not have a known history of congestive heart failure (NYHA class III or IV).\n\n#3. Has the patient experienced weight loss of more than 10% within 3 months prior to study entry?\n\nYes, the patient has experienced weight loss of more than 10% within 3 months prior to study entry.\n\n#4. Does the patient have a known history of pulmonary disease such as pulmonary hypertension, chronic obstructive pulmonary disease requiring medical management, or previous lung resection?\n\nNo, the patient does not have a known history of pulmonary disease such as pulmonary hypertension, chronic obstructive pulmonary disease requiring medical management, or previous lung resection.\n\n#5. Does the patient have current liver cirrhosis?\n\nNo, the patient does not have current liver cirrhosis.\n\n#6. Does the patient have current chronic kidney disease?\n\nYes, the patient has current chronic kidney disease (SCr 2.1 in [**3-17**]).\n\n#7. Is the patient unable or unwilling to receive systemic therapy?\n\nNo, the patient is not unable or unwilling to receive systemic therapy.\n\n#8. Is the patient unable to comply with pulmonary function tests (PFTs)?\n\nNo, the patient is not unable to comply with pulmonary function tests (PFTs).\n\n#9. Does the patient have large volume ascites interfering with ability of respiration?\n\nNo, the patient does not have large volume ascites interfering with ability of respiration.\n\n#10. Does the patient have current unstable angina (or history of within last 6 months)?\n\nNo, the patient does not have current unstable angina (or history of within last 6 months).\n\n#11. Does the patient have recent myocardial infarction (within last 6 months)?\n\nNo, the patient does not have recent myocardial infarction (within last 6 months).\n\n#12. Does the patient have recent pneumothorax (within last 6 months)?\n\nNo, the patient does not have recent pneumothorax (within last 6 months).\n\n#13. Is the patient unwilling to undergo lung biopsy within one week from PFT?\n\nNo, the patient is not unwilling to undergo lung biopsy within one week from PFT.\n\n#14. Does the patient have recent surgery < 4 weeks?\n\nNo, the patient does not have recent surgery < 4 weeks.\n\nBased on the patient's history and the exclusion criteria for the clinical trial, the patient is not eligible for the study.","PROBA":0.9944905574},{"ID":"6620_15-2021_NCT00580749","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have acute pancreatitis?\n\nYes, the patient has acute pancreatitis, so we can proceed to the next criterion.\n\n#2: Is the patient's pancreatitis severe?\n\nYes, the patient has severe acute pancreatitis, as evidenced by the presence of an abdominal mass and bandemia.\n\n#3: Has the patient been receiving artificial feeding since the onset of acute pancreatitis symptoms?\n\nNo, the patient has not been receiving artificial feeding since the onset of acute pancreatitis symptoms. Therefore, the patient meets the inclusion criteria for the clinical trial.\n\nSo, the patient is eligible for the clinical trial.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9966450444},{"ID":"5436_12-2021_NCT03155373","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair or replacement surgery?\n\nYes, the patient is planned for mitral valve repair or replacement surgery.\n\n#4: Does the patient have a history of gestational diabetes mellitus?\n\nNo, the patient does not have a history of gestational diabetes mellitus.\n\n#5: Does the patient have hypertension with pregnancy?\n\nNo, the patient does not have hypertension with pregnancy.\n\n#6: Does the patient have obesity?\n\nYes, the patient has obesity.\n\n#7: Has the patient had previous laser eye surgery?\n\nYes, the patient has had previous laser eye surgery.\n\n#8: Has the patient had previous cataract surgery?\n\nYes, the patient has had previous cataract surgery.\n\n#9: Has the patient had previous foot surgery (shorten bone length)?\n\nYes, the patient has had previous foot surgery (shorten bone length).\n\n#10: Does the patient meet the exclusion criteria for the clinical trial?\n\nNo, the patient does not meet the exclusion criteria for the clinical trial.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the answer is: A: eligible.","PROBA":0.9961330202},{"ID":"6633_15-2021_NCT00663247","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have symptomatic diverticular disease?\n\nYes, the patient has symptoms of diverticulosis, including abdominal pain and changes in bowel habit.\n\n#2: Is the patient taking NSAIDs or long-term antibiotics?\n\nNo, the patient is not taking NSAIDs or long-term antibiotics.\n\n#3: Does the patient have any co-morbidities that would exclude them from the trial?\n\nYes, the patient has a history of coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, and hypothyroidism. These co-morbidities may be exclusionary for the trial.\n\n#4: Is the patient pregnant or lactating?\n\nNo, the patient is not pregnant or lactating.\n\nBased on the information provided, the patient may be excluded from the clinical trial due to their co-morbidities. Therefore, the answer is:\n\nExcluded (B)","PROBA":0.9947840298},{"ID":"6769_15-2021_NCT01919151","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of other malignancy?\n\nNo, the patient does not have a history of other malignancy, so this exclusion criterion is not met.\n\n#2: Does the patient have pancreatic adenocarcinoma at the head of the pancreas?\n\nYes, the patient does have pancreatic adenocarcinoma at the head of the pancreas, which meets the inclusion criterion for the clinical trial.\n\n#3: Does the patient have detectable circulating tumor cells in the blood or disseminated tumor cells in the bone marrow?\n\nThe patient's EUS biopsy results showed pancreatic adenocarcinoma at the head of the pancreas, but there is no information provided about detectable circulating tumor cells in the blood or disseminated tumor cells in the bone marrow. Therefore, this criterion is not met.\n\nBased on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9977062887},{"ID":"6973_15-2021_NCT03661398","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have severe, symptomatic mitral regurgitation (MR)?\n\nYes, the patient has been diagnosed with severe, symptomatic mitral regurgitation (MR) based on the results of the echocardiogram.\n\n#2: Is the patient's left ventricular end diastolic dimension (LVEDD) > 7cm?\n\nNo, the patient's LVEDD is 6.5cm, which is within the normal range.\n\n#3: Does the patient have left ventricular outflow tract obstruction?\n\nNo, there is no mention of left ventricular outflow tract obstruction in the patient's history.\n\n#4: Does the patient have severe right ventricular dysfunction?\n\nNo, there is no mention of severe right ventricular dysfunction in the patient's history.\n\n#5: Has the patient had a stroke within 90 days, a transient ischemic attack or myocardial infarction within 30 days of the index procedure?\n\nNo, there is no mention of any of these conditions in the patient's history.\n\nBased on the above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.996210824},{"ID":"5319_12-2021_NCT01719211","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2. Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3. Is the patient planned for mitral valve repair or replacement surgery?\n\nYes, the patient is planned for mitral valve repair or replacement surgery.\n\n#4. Does the patient have a history of gestational diabetes mellitus?\n\nNo, the patient does not have a history of gestational diabetes mellitus.\n\n#5. Does the patient have hypertension with pregnancy?\n\nNo, the patient does not have hypertension with pregnancy.\n\n#6. Does the patient have obesity?\n\nNo, the patient does not have obesity.\n\n#7. Does the patient have a history of laser eye surgery, cataract surgery, foot surgery (shorten bone length)?\n\nYes, the patient has a history of laser eye surgery, cataract surgery, and foot surgery (shorten bone length).\n\n#8. Does the patient meet the inclusion criteria for the clinical trial?\n\nYes, the patient meets the inclusion criteria for the clinical trial.\n\n#9. Does the patient have any exclusion criteria for the clinical trial?\n\nNo, the patient does not have any exclusion criteria for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\nSo, the answer is: A. Eligible.","PROBA":0.9935218388},{"ID":"35766_75-2021_NCT04250792","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease stage mild, moderate, or severe?\n\nThe patient's disease stage is mild, Hoehn-Yahr Stage I.\n\n#3: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria (hypertension, cardiovascular disorders, pregnancy, lactation, renal failure, liver failure, or hypersensitivity to the drug).\n\nTherefore, based on the information provided, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9941502636},{"ID":"6962_15-2021_NCT03557216","TOPIC_YEAR":2021,"RESPONSE":"import { useState } from 'react';\n\nfunction App() {\n  const [isEligible, setIsEligible] = useState(false);\n\n  const patientNote = '70 year-old woman with a history of CAD recently noted abdominal mass who presents with fevers\/rigors and bandemia. Over the last few weeks leading up to admission, she has been experiencing mid-abdominal pain, radiating to the left flank. It lasts throughout the day is not increased by eating though there is associated vomiting and is worsened with coughing. CT abdomen without contrast was then performed on [**4-20**] showing a large 9.5 x 7.5 x 6.0-cm heterogeneous left upper abdominal mass. Patient underwent a EUS with biopsy. The results of the biopsy were consistent with pancreatic adenocarcinoma at the head of pancreas. Splenic flecture\/pancreatic tail mass was also seen on CT, likely diverticular abscess given the patients recent likely history of diverticulitis this was thought to be an infected fluid collection or abscess. She was treated with IV antibiotics (Zosyn, then ceftriaxone and flagyl) and will continue on them until seen by ID as an outpatient. Past Medical History: 1. Coronary artery disease with history of angioplasty in [**State 108**] one year ago 2. Mitral valve prolapse 3. Atrial fibrillation 4. Hyperlipemia 5. Hypertension 6. Chronic kidney disease (SCr 2.1 in [**3-17**]) 7. Hypothyroidism? (TSH 10 in [**3-17**]) 8. Anemia (HCT 30.7 in [**3-17**])';\n\n  const clinicalTrials = [\n    {\n      title: 'Acute Diverticulitis and Advanced Colonic Neoplasia. When to Perform Colonoscopy (ADACOLON Study)',\n      exclusionCriteria: [\n        'Patient refusal to participate in the study',\n        'Impossibility of obtaining informed consent by the patient or guardian',\n        'Age <18 years and> 85 years',\n        'Impossibility of performing a diagnostic CT of AD',\n        'Intercurrent medical or surgical process with prolonged recovery in time that prevents a colonoscopy before 6 months after the resolution of the episode of acute diverticulitis',\n      ],\n    },\n  ];\n\n  const isEligible = clinicalTrials.find(\n    (trial) =>\n      trial.exclusionCriteria.every((exclusion) => !patientNote.includes(exclusion)) &&\n      trial.interventionType === 'Diagnostic Test',\n  );\n\n  setIsEligible(isEligible);\n\n  return (\n    <div>\n      <h1>Clinical Trial Eligibility<\/h1>\n      <p>\n        Based on the provided patient note and clinical trial information, the patient is{' '}\n        {isEligible ? 'eligible' : 'ineligible'} for the clinical trial.\n      <\/p>\n      <ul>\n        {isEligible ? (\n          <li>\n            The patient meets the inclusion criteria for the clinical trial.\n          <\/li>\n        ) : (\n          <li>\n            The patient does not meet the inclusion criteria for the clinical trial.\n          <\/li>\n        )}\n      <\/ul>\n    <\/div>\n  );\n}\n\nexport default App;","PROBA":0.9967925368},{"ID":"35603_75-2021_NCT02933476","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\nYes, the patient's disease stage is mild.\n\n#3: Does the patient have any exclusion criteria?\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9942003033},{"ID":"7096_15-2021_NCT04805710","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have coronary heart disease?\n\nYes, the patient has a history of coronary artery disease (CAD) and recent angioplasty. Therefore, the patient meets the inclusion criterion of having CHD.\n\n#2. Does the patient have gastrointestinal disease?\n\nYes, the patient has a history of gastrointestinal disease (GD) and recent abdominal mass with fever and bandemia. Therefore, the patient meets the inclusion criterion of having GD.\n\n#3. Is the patient undergoing PCI?\n\nYes, the patient is undergoing PCI as part of their treatment for CAD and GD. Therefore, the patient meets the inclusion criterion of being undergoing PCI.\n\n#4. Does the patient have any exclusion criteria?\n\nBased on the information provided, the patient does not have any of the exclusion criteria listed in the clinical trial. Therefore, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9853441662},{"ID":"17254_36-2021_NCT03206905","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obesity?\n\nYes, the patient is obese.\n\n#2: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria.\n\nTherefore, based on the information provided, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9772066369},{"ID":"14092_30-2021_NCT02393183","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have mild Thyroid Eye Disease (TED)?\n\nYes, the patient has been diagnosed with mild Hashimoto's thyroiditis, which is a type of TED. Therefore, the patient meets the inclusion criterion of having mild TED.\n\n#2: Is the patient's TED severity more than mild?\n\nNo, the patient's TED severity is described as mild. Therefore, the patient does not meet the exclusion criterion of having TED severity of more than mild.\n\n#3: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria listed (pregnancy, drug and\/or alcohol abuse, severe concomitant illness, inability to comply with the study protocol, no informed consent, use of selenium- or vitamin\/minerals-containing preparations in the last 3 months, or developing more severe TED in the course of the trial requiring steroid treatment).\n\nTherefore, based on the information provided, the patient would be considered eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9968050964},{"ID":"33522_71-2021_NCT01075087","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a BMI of 41.5 or higher?\n\nYes, the patient has a BMI of 41.54, which meets the inclusion criterion of BMI 40 or higher.\n\n#2: Is the patient obese?\n\nYes, the patient is obese based on her BMI of 41.54.\n\n#3: Does the patient have a history of prior pregnancies?\n\nNo, the patient does not have a history of prior pregnancies, which meets the exclusion criterion of no prior pregnancies.\n\n#4: Is the patient considering laparoscopic gastric bypass surgery?\n\nYes, the patient is considering laparoscopic gastric bypass surgery, which meets the inclusion criterion of patients undergoing laparoscopic bariatric surgery.\n\n#5: Does the patient have any contraindications to the procedure?\n\nNo, the patient does not have any contraindications to the procedure, which meets the exclusion criterion of no contraindications to the procedure.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9890519108},{"ID":"27977_40-2022_NCT03834727","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have a bleeding disorder?\n\nYes, the patient has a bleeding disorder, as evidenced by the prolonged oral bleeding after tooth extraction and the abnormal ristocetin cofactor assay and CB and FVIII:C levels.\n\n#2: Is the patient a woman or post-menarchal girl?\n\nYes, the patient is a woman.\n\n#3: Is the patient enrolled in the American Thrombosis and Hemostasis Network (ATHN) dataset?\n\nNo, the patient is not enrolled in the ATHN dataset.\n\n#4: Does the patient have heavy menstrual bleeding?\n\nYes, the patient has heavy menstrual cycles each month.\n\n#5: Is the patient eligible for the clinical trial?\n\nNo, the patient is not eligible for the clinical trial because it is only for women and post-menarchal girls with bleeding disorders who are enrolled in the ATHN dataset, and the patient is not enrolled in the ATHN dataset.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9923978873},{"ID":"17040_36-2021_NCT01562678","TOPIC_YEAR":2021,"RESPONSE":"# A: Eligible\n# B: Excluded\n# C: Irrelevant\n\nPlease select one of the options above based on the patient's information and the inclusion\/exclusion criteria of the clinical trial.","PROBA":0.9797824283},{"ID":"5333_12-2021_NCT01899573","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Marfan's syndrome?\n\nYes, the patient has Marfan's syndrome.\n\n#2: Does the patient have severe mitral valve prolapse with regurgitation?\n\nYes, the patient has severe mitral valve prolapse with regurgitation.\n\n#3: Is the patient planned for mitral valve repair\/replacement surgery?\n\nYes, the patient is planned for mitral valve repair\/replacement surgery.\n\n#4: Does the patient have any exclusion criteria?\n\nNo, the patient does not have any exclusion criteria.\n\nTherefore, based on the information provided, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9954085923},{"ID":"16894_36-2021_NCT00362908","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have metabolic syndrome?\n\nYes, the patient has metabolic syndrome, as she has at least three of the following conditions: obesity, hypertension, dyslipidemia, and insulin resistance.\n\n#2: Does the patient have high triglycerides (>500 mg\/dL) or low HDL (<35 mg\/dL) at Visit 1?\n\nNo, the patient's triglycerides are 150 mg\/dL and her HDL is 35 mg\/dL, which is within the normal range.\n\n#3: Is the patient's blood pressure over a mean of 150\/95 at the two first visits?\n\nNo, the patient's blood pressure is 130\/80 mmHg, which is within the normal range.\n\n#4: Does the patient have a body mass index (BMI) greater than 40 kg\/m\u00b2?\n\nNo, the patient's BMI is 32 kg\/m\u00b2, which is within the normal range.\n\n#5: Is the patient currently taking any lipid-lowering medication other than statins?\n\nNo, the patient is not currently taking any lipid-lowering medication.\n\n#6: Is the patient currently taking high doses of thiazide diuretics (>50 mg\/day) or any other blood pressure medication in the past 4 weeks?\n\nNo, the patient is not currently taking any blood pressure medication.\n\n#7: Has the patient used any fish oil supplements in the past week?\n\nNo, the patient has not used any fish oil supplements in the past week.\n\n#8: Does the patient have any of the following conditions: unstable liver, renal, gastrointestinal or pulmonary disease, or mental disease, or is medically unstable for other reasons?\n\nNo, the patient does not have any of these conditions.\n\n#9: Does the patient have a history of coronary disease in the last 6 months?\n\nNo, the patient does not have a history of coronary disease in the last 6 months.\n\n#10: Is the patient currently smoking or using any illegal drugs?\n\nNo, the patient does not currently smoke or use any illegal drugs.\n\nBased on the criteria above, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9955065399},{"ID":"35341_75-2021_NCT00465790","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient over 18 years old?\n\nYes, the patient is over 18 years old.\n\n#3: Does the patient have the ability to understand the aim of the study and sign the consent form?\n\nYes, the patient is alert and cooperative, and has the ability to understand the aim of the study and sign the consent form.\n\nTherefore, based on the inclusion and exclusion criteria provided, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9836880159},{"ID":"25309_53-2021_NCT03349879","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a general and non-specific bone and joint pain?\n\nYes, the patient does have general and non-specific bone and joint pain.\n\n#2: Is the patient's past medical and drug history unremarkable?\n\nYes, the patient's past medical and drug history are unremarkable.\n\n#3: Does the patient have a BMI of 23?\n\nYes, the patient has a BMI of 23.\n\n#4: Is the patient's blood pressure (BP) within the normal range (120\/75)?\n\nYes, the patient's blood pressure is within the normal range (120\/75).\n\n#5: Does the patient have a normal heart rate (HR) of 75\/min?\n\nYes, the patient has a normal heart rate of 75\/min.\n\n#6: Are the patient's laboratory results remarkable for Vit D: 14ng\/ml and otherwise healthy?\n\nYes, the patient's laboratory results are remarkable for Vit D: 14ng\/ml and otherwise healthy.\n\n#7: Does the patient have a family history of vitamin D deficiency?\n\nNo, the patient does not have a family history of vitamin D deficiency.\n\n#8: Is the patient's BMI within the normal range?\n\nYes, the patient's BMI is within the normal range (23).\n\n#9: Does the patient have any other health conditions that would exclude them from the study?\n\nNo, the patient does not have any other health conditions that would exclude them from the study.\n\nBased on the criteria for the clinical trial, the patient is eligible for the study. Therefore, the answer is:\n\nA: Eligible","PROBA":0.989858619},{"ID":"27957_40-2022_NCT03699176","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have heavy menstrual bleeding?\nYes, the patient has heavy menstrual bleeding.\n\n#2: Does the patient have uterine fibroids?\nNo, the patient does not have uterine fibroids.\n\n#3: Is the patient pregnant or lactating?\nNo, the patient is not pregnant or lactating.\n\n#4: Does the patient have any conditions that could compromise the function of the body systems?\nNo, the patient does not have any conditions that could compromise the function of the body systems.\n\n#5: Does the patient have any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results?\nNo, the patient does not have any diseases or conditions that might interfere with the conduct of the study or the interpretation of the results.\n\nBased on the criteria above, the patient is not eligible for the clinical trial because she does not have uterine fibroids, which is a requirement for participation in the study. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9969766834},{"ID":"17104_36-2021_NCT02104817","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hypertriglyceridemia?\n\nYes, the patient has hypertriglyceridemia (elevated triglycerides) with a value of 150 mg\/dL.\n\n#2: Does the patient have low HDL?\n\nYes, the patient has low HDL (less than 40 mg\/dL) with a value of 35 mg\/dL.\n\n#3: Is the patient at high risk for CVD?\n\nYes, the patient is at high risk for CVD based on her age (32 years old), obesity (BMI 41.54), and family history of CVD (her husband was diagnosed with colon cancer).\n\n#4: Is the patient statin-naive?\n\nNo, the patient is not statin-naive. She is currently taking a statin.\n\nBased on the above criteria, the patient is not eligible for the clinical trial because she is statin-naive and has been taking a statin for the past 4 weeks. Therefore, the patient is \"excluded\" from the clinical trial.","PROBA":0.9902334449},{"ID":"33881_71-2021_NCT04050553","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have type 2 diabetes?\n\nYes, the patient has type 2 diabetes.\n\n#2: Is the patient considering a laparoscopic gastric bypass?\n\nNo, the patient is not considering a laparoscopic gastric bypass.\n\n#3: Does the patient have any of the exclusion criteria?\n\nYes, the patient has impaired renal estimated glomerular filtration rate (eGFR) <60 milliliters per minute per 1.73 square meters (mL\/min\/1.73 m\u00b2) calculated by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI).\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the answer is: B: Excluded.","PROBA":0.9967104817},{"ID":"35527_75-2021_NCT02256319","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease stage mild (Hoehn-Yahr Stage I)?\n\nYes, the patient's disease stage is mild (Hoehn-Yahr Stage I).\n\n#3: Does the patient have any of the exclusion criteria?\n\nNo, the patient does not have any of the exclusion criteria (allergy or hypersensibility to dexmedetomidine or propofol, cardiac blockade, low blood pressure, severe cerebrovascular disease, pregnancy, or nursing mothers).\n\nTherefore, based on the information provided, the patient would be eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9941286141},{"ID":"17306_36-2021_NCT03599921","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have an eating disorder?\n\nNo, the patient does not have an eating disorder. She is concerned about her weight and body shape, but she does not meet the criteria for an eating disorder.\n\n#2: Does the patient have a co-morbid medical disorder known to influence eating or weight?\n\nNo, the patient does not have a co-morbid medical disorder known to influence eating or weight.\n\n#3: Does the patient present with a significant psychotic disorder?\n\nNo, the patient does not present with a significant psychotic disorder.\n\n#4: Is the patient acutely suicidal?\n\nNo, the patient is not acutely suicidal.\n\n#5: Does the patient demonstrate significant substance abuse and\/or substance dependence?\n\nNo, the patient does not demonstrate significant substance abuse and\/or substance dependence.\n\nBased on the criteria for the clinical trial, the patient is not eligible for the study. Therefore, the answer is:\n\nB: Excluded.","PROBA":0.9953180645},{"ID":"13920_30-2021_NCT00009958","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a solid tumor?\n\nYes, the patient has a solid tumor ( Hashimoto's thyroiditis).\n\n#2: Is the patient willing to practice an effective method of birth control for at least six months after their last treatment on protocol?\n\nYes, the patient is willing to practice an effective method of birth control.\n\n#3: Does the patient have any history (past or present) of allergy to eggs or egg products?\n\nNo, the patient does not have any history of allergy to eggs or egg products.\n\n#4: Has the patient recovered completely from any reversible toxicity associated with their most recent therapy?\n\nYes, the patient has recovered completely from any reversible toxicity associated with their most recent therapy.\n\n#5: Does the patient have clinically active brain metastasis, uncontrolled seizure disorders, encephalitis, or multiple sclerosis?\n\nNo, the patient does not have clinically active brain metastasis, uncontrolled seizure disorders, encephalitis, or multiple sclerosis.\n\n#6: Does the patient have a history of receiving CEA-containing vaccines?\n\nNo, the patient does not have a history of receiving CEA-containing vaccines.\n\nBased on the criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9914026891},{"ID":"6589_15-2021_NCT00265525","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Coronary Artery Disease (CAD)?\n\nYes, the patient has a history of CAD, which meets the inclusion criterion.\n\n#2: Is the patient intending to enroll in structured cardiac rehabilitation?\n\nNo, the patient is not intending to enroll in structured cardiac rehabilitation, which meets the exclusion criterion.\n\n#3: Has the patient had a hospitalization for Coronary Artery Bypass (CABG)?\n\nNo, the patient has not had a hospitalization for CABG, which meets the exclusion criterion.\n\n#4: Has the patient had a hospitalization for diagnostic procedure not associated with previously documented MI?\n\nNo, the patient has not had a hospitalization for a diagnostic procedure not associated with previously documented MI, which meets the exclusion criterion.\n\n#5: Is the patient coming back to hospital for planned staged PCI within 6 months?\n\nNo, the patient is not coming back to hospital for planned staged PCI within 6 months, which meets the exclusion criterion.\n\n#6: Has the patient had a cardiac transplantation?\n\nNo, the patient has not had a cardiac transplantation, which meets the exclusion criterion.\n\n#7: Is the patient having or has the patient had a defibrillator implant?\n\nNo, the patient is not having or has not had a defibrillator implant, which meets the exclusion criterion.\n\n#8: Has the patient had a pacemaker implantation?\n\nNo, the patient has not had a pacemaker implantation, which meets the exclusion criterion.\n\n#9: Does the patient have unresolved unstable angina &\/or hospitalization for angina (without MI or PCI)?\n\nNo, the patient does not have unresolved unstable angina &\/or hospitalization for angina (without MI or PCI), which meets the exclusion criterion.\n\n#10: Does the patient have other uncontrolled metabolic conditions (e.g. diabetes)?\n\nNo, the patient does not have other uncontrolled metabolic conditions (e.g. diabetes), which meets the exclusion criterion.\n\n#11: Does the patient have chronic infectious diseases such as mononucleosis, hepatitis, AIDS?\n\nNo, the patient does not have chronic infectious diseases such as mononucleosis, hepatitis, AIDS, which meets the exclusion criterion.\n\n#12: Does the patient have acute systematic illness or fever?\n\nNo, the patient does not have acute systematic illness or fever, which meets the exclusion criterion.\n\n#13: Does the patient have uncontrolled tachycardia (<120 bpm)?\n\nNo, the patient does not have uncontrolled tachycardia (<120 bpm), which meets the exclusion criterion.\n\n#14: Does the patient have uncompensated congestive heart failure (&\/or NYHA Class III, or IV)?\n\nNo, the patient does not have uncompensated congestive heart failure (&\/or NYHA Class III, or IV), which meets the exclusion criterion.\n\n#15: Does the patient have 3rd degree AV block without pacemaker?\n\nNo, the patient does not have 3rd degree AV block without pacemaker, which meets the exclusion criterion.\n\n#16: Does the patient have active pericarditis or myocarditis?\n\nNo, the patient does not have active pericarditis or myocarditis, which meets the exclusion criterion.\n\n#17: Does the patient have recent embolism?\n\nNo, the patient does not have recent embolism, which meets the exclusion criterion.\n\n#18: Does the patient have suspected or known AAA aneurysm > 4cm?\n\nNo, the patient does not have suspected or known AAA aneurysm > 4cm, which meets the exclusion criterion.\n\n#19: Does the patient have uncontrolled hypertension (SBP > 200; DBP > 110)?\n\nNo, the patient does not have uncontrolled hypertension (SBP > 200; DBP > 1","PROBA":0.9978400775},{"ID":"33778_71-2021_NCT03200769","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obstructive sleep apnea syndrome?\n\n#2: Is the patient pharmacoresistant epilepsy?\n\n#3: Is the patient willing to undergo CPAP treatment?\n\n#4: Does the patient have any of the exclusion criteria?\n\nPlease answer the questions with a \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial.","PROBA":0.9863783464},{"ID":"17229_36-2021_NCT03083964","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have severe illness that might be associated with weight loss, such as cancer?\n\nNo, the patient does not have any history of cancer or any other severe illness that might be associated with weight loss. Therefore, the patient does not meet the exclusion criterion #1.\n\n#2. Does the patient use weight loss medications?\n\nNo, the patient does not use any weight loss medications. Therefore, the patient does not meet the exclusion criterion #2.\n\n#3. Does the patient have a history of bipolar disorder or psychosis?\n\nNo, the patient does not have any history of bipolar disorder or psychosis. Therefore, the patient does not meet the exclusion criterion #3.\n\n#4. Does the patient have severe cognitive impairment (\u22653 errors on a 6-item cognitive screen)?\n\nNo, the patient does not have any severe cognitive impairment. Therefore, the patient does not meet the exclusion criterion #4.\n\n#5. Is the patient unwilling or unable to provide informed consent?\n\nNo, the patient is willing and able to provide informed consent. Therefore, the patient does not meet the exclusion criterion #5.\n\n#6. Has the patient had bariatric surgery already completed or planned within 12 months?\n\nNo, the patient has not had any bariatric surgery and does not have any plans to do so within 12 months. Therefore, the patient does not meet the exclusion criterion #6.\n\n#7. Is the patient pregnant or nursing in the past 6 months, or plans to become so within 12 months?\n\nNo, the patient is not pregnant or nursing, and does not have any plans to become so within 12 months. Therefore, the patient does not meet the exclusion criterion #7.\n\n#8. Does the patient reside outside of Marion County, Indiana?\n\nNo, the patient resides within Marion County, Indiana. Therefore, the patient does not meet the exclusion criterion #8.\n\n#9. Does the patient have a history of substance abuse (for alcohol; \u22652 on CAGE questionnaire)?\n\nNo, the patient does not have any history of substance abuse. Therefore, the patient does not meet the exclusion criterion #9.\n\n#10. Does the patient currently smoke or use tobacco?\n\nNo, the patient does not currently smoke or use tobacco. Therefore, the patient does not meet the exclusion criterion #10.\n\nBased on the above assessment, the patient is eligible for the clinical trial. Therefore, the patient is \"eligible\" for the clinical trial.","PROBA":0.9942269367},{"ID":"35606_75-2021_NCT02965352","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have Parkinson's disease?\n\nYes, the patient has been diagnosed with Parkinson's disease.\n\n#2: Is the patient's disease ranked as mild, Hoehn-Yahr Stage I?\n\nYes, the patient's disease is ranked as mild, Hoehn-Yahr Stage I.\n\n#3: Is the patient over the age of 7 and under the age of 10?\n\nNo, the patient is 55 years old, which is outside of the age range of 7-10 years old.\n\n#4: Does the patient have any compromise skeletal muscle in the upper limbs?\n\nNo, the patient does not have any compromise skeletal muscle in the upper limbs.\n\n#5: Is the patient willing to participate in the research?\n\nNot applicable, as the patient is not being asked to participate in the research.\n\nBased on the criteria, the patient is not eligible for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.998042424},{"ID":"6924_15-2021_NCT03279588","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of CAD?\n\nYes, the patient has a history of CAD.\n\n#2: Does the patient have a recent history of diverticulitis?\n\nYes, the patient has a recent history of diverticulitis.\n\n#3: Is the patient undergoing imaging study?\n\nYes, the patient underwent EUS with biopsy.\n\n#4: Is the patient's clinical condition particularly severe, preventing an adequate enrollment?\n\nNo, the patient is not in a particularly severe condition.\n\nBased on the above criteria, the patient is eligible for the clinical trial.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9889319598},{"ID":"6864_15-2021_NCT02722551","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have any prior surgical or transcatheter repair (excluding balloon valvuloplasty) or replacement of the mitral valve?\n\nNo, the patient does not have any prior surgical or transcatheter repair or replacement of the mitral valve, so this exclusion criterion does not apply.\n\n#2. Does the patient have any active infection?\n\nNo, the patient does not have any active infection, so this exclusion criterion does not apply.\n\n#3. Does the patient have limited life expectancy (< 12 months)?\n\nNo, the patient does not have limited life expectancy, so this exclusion criterion does not apply.\n\n#4. Does the patient have clinically significant, untreated coronary artery disease?\n\nYes, the patient has a history of coronary artery disease with angioplasty in [**State 108**] one year ago, which is considered clinically significant and untreated. This exclusion criterion applies.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they have clinically significant, untreated coronary artery disease. Therefore, the answer is \"excluded\".","PROBA":0.9889302646},{"ID":"17205_36-2021_NCT02880709","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have hematological cancer?\n\nNo, the patient does not have hematological cancer.\n\n#2: Is the patient undergoing chemotherapy?\n\nNo, the patient is not undergoing chemotherapy.\n\n#3: Does the patient have a BMI of 41.54?\n\nYes, the patient has a BMI of 41.54, which is above the inclusion criteria of BMI < 40.\n\n#4: Is the patient willing and able to understand the information given and the conditions of the experiment?\n\nYes, the patient is willing and able to understand the information given and the conditions of the experiment.\n\nTherefore, the patient is not eligible for the clinical trial because they do not meet the inclusion criteria of having hematological cancer and being undergoing chemotherapy, and they have a BMI above the specified limit.\n\nSo, the patient is \"excluded\" from the clinical trial.","PROBA":0.9932475258},{"ID":"17349_36-2021_NCT04093947","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have overweight or obesity?\n\nYes, the patient has obesity (BMI \u2265 25 Kg \/ m2).\n\n#2. Is the patient free of any drug treatment at the baseline?\n\nNo, the patient is not free of any drug treatment at the baseline.\n\n#3. Does the patient have any of the exclusion criteria?\n\nYes, the patient has hypertension.\n\nTherefore, the patient is not eligible for the clinical trial.\n\nSo, the answer is \"B: Excluded\".","PROBA":0.9815949132},{"ID":"17397_36-2021_NCT04378101","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of subthreshold disordered eating behaviors?\n\nNo, the patient does not have a history of subthreshold disordered eating behaviors. Therefore, the patient meets the exclusion criteria and is not eligible for the clinical trial.\n\nSo, the final answer is:\n\nB: Excluded","PROBA":0.9989376463},{"ID":"25134_53-2021_NCT01832623","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of treatment with growth hormone?\n\nNo, the patient does not have a history of treatment with growth hormone. Therefore, this exclusion criterion does not apply.\n\n#2: Does the patient have a history of treatment with oral corticosteroids taken over more than 3 consecutive months?\n\nNo, the patient does not have a history of treatment with oral corticosteroids. Therefore, this exclusion criterion does not apply.\n\n#3: Is the patient currently being treated with growth hormone, corticosteroids, or anti-calcineurin?\n\nNo, the patient is not currently being treated with any of these medications. Therefore, this exclusion criterion does not apply.\n\n#4: Has the patient been treated with aspirin or nonsteroidal anti-inflammatory drugs within the last three weeks?\n\nNo, the patient has not been treated with aspirin or nonsteroidal anti-inflammatory drugs within the last three weeks. Therefore, this exclusion criterion does not apply.\n\n#5: Has the patient been treated with paracetamol within the last week?\n\nNo, the patient has not been treated with paracetamol within the last week. Therefore, this exclusion criterion does not apply.\n\n#6: Does the patient have a chronic pathology with an impact on growth (such as parenteral nutrition, chronic inflammatory disease, system diseases, renal failure, diabetes, serious intercurrent disease, or ongoing pregnancy)?\n\nNo, the patient does not have any of these chronic pathologies. Therefore, this exclusion criterion does not apply.\n\n#7: Is the patient unaffiliated with the French universal healthcare system?\n\nNo, the patient is not unaffiliated with the French universal healthcare system. Therefore, this exclusion criterion does not apply.\n\nBased on the information provided, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.9951530678},{"ID":"6931_15-2021_NCT03325829","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of diverticular disease?\n\nNo, the patient does not have a history of diverticular disease. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\nSo, the patient is \"excluded\" from the clinical trial.\n\n\nPlease select one of the following options:\n\nA) Eligible\nB) Excluded\nC) Irrelevant\n\nPlease select one of the following options:\n\nA) Eligible\nB) Excluded\nC) Irrelevant","PROBA":0.9815213417},{"ID":"14062_30-2021_NCT01994200","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have thyroid cancer?\nNo, the patient has Hashimoto's thyroiditis, which is an autoimmune disease that affects the thyroid gland. It is not considered thyroid cancer. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\n#2: Does the patient have a Karnofsky Performance Status (KPS) score <60 or expected survival <6 months according to clinical judgment?\nNo, the patient's KPS score is not provided in the information given, and there is no information about their expected survival. Therefore, the patient does not meet the exclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is not eligible for the clinical trial. Therefore, the answer is [B] Excluded.","PROBA":0.9924763815},{"ID":"23200_33-2022_NCT01080482","TOPIC_YEAR":2022,"RESPONSE":"#1: Does the patient have Marfan syndrome?\nYes, the patient has Marfan syndrome.\n\n#2: Is the patient male?\nYes, the patient is male.\n\n#3: Is the patient at least 18 years old?\nNo, the patient is 20 years old.\n\n#4: Does the patient have any medical or surgical conditions that might significantly interfere with the functioning of the gastrointestinal tract, blood-forming organs, etc.?\nNo, the patient does not have any such conditions.\n\n#5: Has the patient ever participated in a clinical drug study or bioequivalence study within the past 90 days?\nNo, the patient has not.\n\n#6: Does the patient have any history or presence of malignancy or other serious diseases?\nNo, the patient does not have any such history or presence.\n\n#7: Is the patient willing and able to abstain from food for at least ten (10) hours prior to administration of the study drug and for four (4) additional hours each, post dose during each study period?\nNo, the patient is not willing to abstain from food for the required period.\n\n#8: Is the patient willing and able to abstain from water for at least one (1) hour prior to study drug administration on dosing day of each study period and for at least two (2) additional hours, post dosing except 240 mL administered during administration of the dose?\nNo, the patient is not willing to abstain from water for the required period.\n\n#9: Has the patient used xanthine-containing beverages or food and grapefruit or grapefruit products within the past 48 hours?\nNo, the patient has not.\n\n#10: Does the patient have any contraindication to blood sampling?\nNo, the patient does not have any such contraindication.\n\n#11: Is the patient willing and able to refrain from smoking or consumption of tobacco products 24 hours before dosing until last sample collection of each period?\nNo, the patient is not willing to refrain from smoking or consumption of tobacco products.\n\n#12: Has the patient ever had a positive HIV test, HBsAg, or Hepatitis-C test?\nNo, the patient has not.\n\n#13: Does the patient have any hypersensitivity to Tacrolimus or related group of drugs or any excipients of the products?\nNo, the patient does not have any such hypersensitivity.\n\nBased on the criteria for the clinical trial, the patient is not eligible because they do not meet criteria #7 and #8. The patient is not willing and able to abstain from food and water for the required periods. Therefore, the patient is \"not eligible\" for the clinical trial.","PROBA":0.9931401348},{"ID":"7091_15-2021_NCT04730765","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have a history of sigmoid diverticulitis?\n\nNo, the patient does not have a history of sigmoid diverticulitis.\n\n#2: Is the patient undergoing emergency surgery for sigmoid diverticulitis due to a complication?\n\nNo, the patient is not undergoing emergency surgery for sigmoid diverticulitis due to a complication.\n\n#3: Does the patient have a history of colorectal cancer?\n\nNo, the patient does not have a history of colorectal cancer.\n\n#4: Is the patient operated on for diverticulitis of the right colon?\n\nNo, the patient is not operated on for diverticulitis of the right colon.\n\n#5: Does the patient have a history of neoplastic disease under treatment and\/or evolving?\n\nNo, the patient does not have a history of neoplastic disease under treatment and\/or evolving.\n\nBased on the criteria listed in the exclusion criteria, the patient is eligible for the clinical trial.\n\nTherefore, the answer is:\n\nA: Eligible","PROBA":0.987303486},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient meet the inclusion criteria?\n\nThe patient is an elderly adult woman with abnormal weight gain, which meets the inclusion criterion of being an elderly adult woman.\n\n#2: Does the patient have any exclusion criteria?\n\nThe patient has a history of sleep apnea, which is not listed as an exclusion criterion. However, the patient's history of PCO may be relevant to the study, as it could affect hormone levels and metabolism, which are factors that could influence weight loss and lipid profile.\n\n#3: Is the patient eligible for the clinical trial?\n\nBased on the information provided, the patient is eligible for the clinical trial, as she meets the inclusion criteria and does not have any exclusion criteria that would disqualify her from participating.\n\nSo, the patient is \"eligible\" for the clinical trial.","PROBA":0.9881416815},{"ID":"17422_36-2021_NCT04616339","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obesity or being overweight?\n\nYes, the patient is overweight (BMI = 41.54) and has obesity. Therefore, this criterion is met.\n\n#2: Does the patient have any clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurological, or allergic disease?\n\nNo, the patient does not have any of these conditions. Therefore, this criterion is not met.\n\n#3: Has the patient had any recent (within the past year) or active suicidal ideation\/behavior?\n\nNo, there is no mention of suicidal ideation or behavior in the patient's history. Therefore, this criterion is not met.\n\n#4: Is the patient currently using any prescription or nonprescription drugs or dietary and herbal supplements?\n\nNo, the patient is not currently using any medications or supplements. Therefore, this criterion is met.\n\n#5: Does the patient have a history of HIV infection, hepatitis B, or hepatitis C?\n\nNo, there is no mention of a history of HIV infection, hepatitis B, or hepatitis C. Therefore, this criterion is not met.\n\n#6: Does the patient have any condition that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study?\n\nNo, there is no mention of any condition that would increase the risk of study participation or make the patient inappropriate for the study. Therefore, this criterion is met.\n\nBased on the criteria listed above, the patient is eligible for the clinical trial. Therefore, the answer is:\n\nA: Eligible.","PROBA":0.992881941},{"ID":"33941_71-2021_NCT04548232","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have obesity?\nYes, the patient has obesity, as evidenced by her BMI of 41.5.\n\n#2: Does the patient have any secondary causes of obesity?\nNo, there is no mention of any secondary causes of obesity, such as hypothalamic obesity, Cushing syndrome, or hypophysis dysfunction.\n\n#3: Is the patient pregnant or lactating?\nNo, the patient is not pregnant or lactating.\n\n#4: Does the patient have any contraindications for laparoscopic surgery?\nNo, there is no mention of any contraindications for laparoscopic surgery, such as gastrointestinal diseases of intra-abdominal infection, adhesions, etc.\n\n#5: Does the patient have severe heart, liver, or kidney dysfunction?\nNo, there is no mention of any severe heart, liver, or kidney dysfunction.\n\n#6: Does the patient have any organic or systemic diseases intolerant of surgery?\nNo, there is no mention of any organic or systemic diseases intolerant of surgery.\n\nBased on the criteria listed in the exclusion criteria, the patient is eligible for the clinical trial.\n\nTherefore, the patient is eligible for the clinical trial.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9966347508},{"ID":"6877_15-2021_NCT02818829","TOPIC_YEAR":2021,"RESPONSE":"#1: Does the patient have histologically or cytologically confirmed pancreatic adenocarcinoma?\n\nNo, the patient does not have histologically or cytologically confirmed pancreatic adenocarcinoma. The patient has a diagnosis of pancreatic adenocarcinoma based on EUS with biopsy, but this is not the same as having histologically or cytologically confirmed pancreatic adenocarcinoma. Therefore, the patient does not meet the inclusion criteria for the clinical trial.\n\n#2: Is the patient pregnant?\n\nNo, the patient is not pregnant. Therefore, the patient does not meet the exclusion criteria for the clinical trial.\n\n#3: Has the patient given informed consent?\n\nNo information is provided about the patient's informed consent. Therefore, it is unclear whether the patient meets the inclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is not eligible for the clinical trial because they do not have histologically or cytologically confirmed pancreatic adenocarcinoma.","PROBA":0.9912527667}]
